mhurhangee/ep-ind-claims huggingface dataset:
An evaporator capable of accurately quantifying a concentrated liquid, comprising a support frame, wherein a detachable distillation flask and a detachable condenser are fixed on the support frame, the distillation flask is configured to be heated through a heating assembly, and a bottom of the condenser is connected to a collecting flask; a distillation flask liquid discharge opening is formed at the bottom of a work position of the distillation flask, and the distillation flask liquid discharge opening is connected to a concentrated liquid quantification assembly configured to realize accurate quantitative control of the concentrated liquid; wherein the concentrated liquid quantification assembly is a quantitative tube with quantitative scale lines, and liquid discharge of the concentrated liquid and sealing of the distillation flask are controlled through a second liquid discharge valve disposed at the bottom of the quantitative tube; and a first liquid discharge valve is disposed at the distillation flask liquid discharge opening, and configured to perform accurate discharge control of the concentrated liquid and sealing of the distillation flask; characterized in that the evaporator is a rotary evaporator; the heating assembly is an electric heating belt disposed at an outer wall of the distillation flask, and a temperature controller sensor probe is further disposed between the electric heating belt and the distillation flask, wherein the quantitative tube is a metering fine tube with a cavity of a fine tubular structure, and its metering capacity is suitable to be a value in a range of 1 to 10 mL, wherein its metering scale is accurate to 0.01 mL or even 0.005 mL. a distillation flask liquid discharge opening is formed at the bottom of a work position of the distillation flask, and the distillation flask liquid discharge opening is connected to a concentrated liquid quantification assembly configured to realize accurate quantitative control of the concentrated liquid; wherein the concentrated liquid quantification assembly is a quantitative tube with quantitative scale lines, and liquid discharge of the concentrated liquid and sealing of the distillation flask are controlled through a second liquid discharge valve disposed at the bottom of the quantitative tube; and a first liquid discharge valve is disposed at the distillation flask liquid discharge opening, and configured to perform accurate discharge control of the concentrated liquid and sealing of the distillation flask; characterized in that the evaporator is a rotary evaporator; the heating assembly is an electric heating belt disposed at an outer wall of the distillation flask, and a temperature controller sensor probe is further disposed between the electric heating belt and the distillation flask, wherein the quantitative tube is a metering fine tube with a cavity of a fine tubular structure, and its metering capacity is suitable to be a value in a range of 1 to 10 mL, wherein its metering scale is accurate to 0.01 mL or even 0.005 mL.
A hydromassage device comprising a rotatable nozzle and an electric motor for rotating the nozzle, which motor is positioned in close proximity with respect to the nozzle, characterized in that a drive shaft of the motor is coaxially arranged with respect to the axis of rotation of the nozzle.
Wet-rotor motor pump with a motor housing, a stator surrounded by the motor housing, a separating can, a rotor separated from the stator by the separating can, a rotor chamber formed by the separating can in which the rotor runs, a shaft and a pump impeller that is connected to the rotor by the shaft, and a radial bearing on the hydraulics side, in which the motor housing at its end facing the pump impeller has an inward-facing motor housing flange that, at least on the side facing the pump impeller, is covered by a protective layer, characterised by the protective layer between the motor housing flange and the shaft surrounding the hydraulic-side radial bearing and assuming the function of a bearing support together with the motor housing flange.
A method for encapsulating a RNA molecule encoding a TALE-Nuclease, comprising the steps of a) Engineering a RNA molecule encoding a TALE-Nuclease; b) Complexing the RNA molecule encoding said TALE-Nuclease with at least one biodegradable matrix comprising at least a core hydrophobic domain and a proximal polar domain to favor interactions with water molecules; c) Forming particles encapsulating said RNA molecule encoding said TALE-Nuclease of 50 to 100 nm diameter range; wherein said TALE-Nuclease binds a target sequence selected from SEQ ID NO: 59 to 78. a) Engineering a RNA molecule encoding a TALE-Nuclease; b) Complexing the RNA molecule encoding said TALE-Nuclease with at least one biodegradable matrix comprising at least a core hydrophobic domain and a proximal polar domain to favor interactions with water molecules; c) Forming particles encapsulating said RNA molecule encoding said TALE-Nuclease of 50 to 100 nm diameter range;
A bispecific antibody comprising (i) a first heavy chain and a first light chain connected via disulfide bridges forming a first binding region that binds to human CD3 and (ii) a second heavy chain and a second light chain connected via disulfide bridges forming a second binding region that binds to human CD20; wherein the first heavy chain comprises the VH sequence as set forth in SEQ ID NO:6, and the first light chain comprises the VL sequence as set forth in SEQ ID NO:10; and the second heavy chain comprises the VH sequence as set forth in SEQ ID NO:29, and the second light chain comprises the VL sequence as set forth in SEQ ID NO:30; wherein the first and the second heavy chains comprise modified IgG1 constant regions, wherein in both the first and second heavy chains the amino acids in the positions corresponding to positions L234, L235, and D265 in a human IgG1 heavy chain are F, E, and A, respectively; wherein in the first heavy chain the amino acid in the position corresponding to position F405 in a human IgG1 heavy chain is L, and in the second heavy chain the amino acid in the position corresponding to position K409 in a human IgG1 heavy chain is R; wherein said amino acid positions are in accordance with Eu-numbering. wherein the first heavy chain comprises the VH sequence as set forth in SEQ ID NO:6, and the first light chain comprises the VL sequence as set forth in SEQ ID NO:10; and the second heavy chain comprises the VH sequence as set forth in SEQ ID NO:29, and the second light chain comprises the VL sequence as set forth in SEQ ID NO:30; wherein the first and the second heavy chains comprise modified IgG1 constant regions, wherein in both the first and second heavy chains the amino acids in the positions corresponding to positions L234, L235, and D265 in a human IgG1 heavy chain are F, E, and A, respectively; wherein in the first heavy chain the amino acid in the position corresponding to position F405 in a human IgG1 heavy chain is L, and in the second heavy chain the amino acid in the position corresponding to position K409 in a human IgG1 heavy chain is R; wherein said amino acid positions are in accordance with Eu-numbering.
A method, comprising providing a virtual layer-2 network, comprising a first machine (316) and a second machine (316), over a layer-3 infrastructure comprising switches (310, 706, 806, 906) communicatively coupled together through many paths, wherein the providing comprises: assigning application addresses associated with the virtual layer-2 network to the first and second machines, the first and second machines being able to communicate to each other via their respective assigned application addresses; and assigning location addresses to the switches of the layer-3 infrastructure; receiving, at an agile agent associated with the first machine, a packet of a packet flow having an assigned application address of the second machine; encapsulating, at the first machine (316), the packet of the packet flow with a location address of one of the switches of the layer-3 infrastructure (310, 706, 806, 906), the location address being mapped to the application address of the second machine by the agile agent; and transmitting the encapsulated packet to the one of the switches of the layer-3 infrastructure (310, 706, 806, 906), which decapsulates the encapsulated packet and transmits the decapsulated packet to the second machine; the method further comprising: randomly selecting, by the agile agent, an individual path through the switches of the layer-3 infrastructure for the transmission of the packets of the packet flow between the first and second machines; and reselecting, by the agile agent, the randomly selected individual path either periodically or responsive to a network performance parameter. assigning application addresses associated with the virtual layer-2 network to the first and second machines, the first and second machines being able to communicate to each other via their respective assigned application addresses; and assigning location addresses to the switches of the layer-3 infrastructure; receiving, at an agile agent associated with the first machine, a packet of a packet flow having an assigned application address of the second machine; encapsulating, at the first machine (316), the packet of the packet flow with a location address of one of the switches of the layer-3 infrastructure (310, 706, 806, 906), the location address being mapped to the application address of the second machine by the agile agent; and transmitting the encapsulated packet to the one of the switches of the layer-3 infrastructure (310, 706, 806, 906), which decapsulates the encapsulated packet and transmits the decapsulated packet to the second machine; randomly selecting, by the agile agent, an individual path through the switches of the layer-3 infrastructure for the transmission of the packets of the packet flow between the first and second machines; and reselecting, by the agile agent, the randomly selected individual path either periodically or responsive to a network performance parameter.
An additive manufacturing method comprising: using hydrogenated titanium in forming an object by additive manufacturing, the object having a first microstructure; heat treating the hydrogenated titanium between 500 and 1,200 °C; and after completing a shape of the object, dehydrogenating the object under vacuum between 500 and 1,200 °C, the completed shape containing 0.5 to 1.2 weight % hydrogen before the dehydrogenating and the dehydrogenated object having a second microstructure different from the first microstructure, wherein the second microstructure exhibits finer structure compared to the first microstructure, such that the dehydrogenated object exhibits an alpha colony size, in the smallest dimension of the alpha colonies, of less than 25 microns and an acicular alpha phase width, in the smallest dimension of the acicular alpha phase in alpha colonies and in grain boundaries, of less than 10 microns. using hydrogenated titanium in forming an object by additive manufacturing, the object having a first microstructure; heat treating the hydrogenated titanium between 500 and 1,200 °C; and after completing a shape of the object, dehydrogenating the object under vacuum between 500 and 1,200 °C, the completed shape containing 0.5 to 1.2 weight % hydrogen before the dehydrogenating and the dehydrogenated object having a second microstructure different from the first microstructure, wherein the second microstructure exhibits finer structure compared to the first microstructure, such that the dehydrogenated object exhibits an alpha colony size, in the smallest dimension of the alpha colonies, of less than 25 microns and an acicular alpha phase width, in the smallest dimension of the acicular alpha phase in alpha colonies and in grain boundaries, of less than 10 microns.
A method for discovering 2nd Generation mobile communication system, 2G, neighbour cells at the edge of an area covered by a 3rd Generation mobile communication system, 3G, cell, characterized by comprising: - based on measurement reports, MR, in the 2G system, generating lists, Li, of signal quality assessment results, RxLev, of the 2G cells, each list being generated for a geographical grid according to the geographical distribution of the MR, and wherein, in each grid, the cells are grouped by a Cell Global Identity, CGI, and are filtered so that only those whose RxLev meet the level threshold of a 2G cell in a 3A event are included in the list Li; - determining a network edge for the 3G-2G handover as a linear or planar area composed of geographical grids, wherein each grid can be located for each value in a list obtained by combining a MR of a 2D event and a MR of location reported by a UE; - merging the lists Li whose geographical grids correspond to the ones included in the determined network edge so as to determine the candidate 2G neighbor cell which are most suitable for the handover. - based on measurement reports, MR, in the 2G system, generating lists, Li, of signal quality assessment results, RxLev, of the 2G cells, each list being generated for a geographical grid according to the geographical distribution of the MR, and wherein, in each grid, the cells are grouped by a Cell Global Identity, CGI, and are filtered so that only those whose RxLev meet the level threshold of a 2G cell in a 3A event are included in the list Li; - determining a network edge for the 3G-2G handover as a linear or planar area composed of geographical grids, wherein each grid can be located for each value in a list obtained by combining a MR of a 2D event and a MR of location reported by a UE; - merging the lists Li whose geographical grids correspond to the ones included in the determined network edge so as to determine the candidate 2G neighbor cell which are most suitable for the handover.
A dynamic graphic code, representing, in encoded manner, a security, - said security being formed by a sequence of alphanumeric characters and/or symbols, characterized in that - said dynamic graphic code consisting in a timely sequence of graphic codes to be provided on a display, - each graphic code of the sequence being a bar code or QR code containing information, - said information contained in each graphic code of the said sequence comprises a fixed part and a variable part, - each variable part being time dependent, - each variable part is encoded together with the respective fixed part thereby forming said sequence of different graphic codes, - each fixed part contains said security, - each fixed part can be determined by comparing two or more subsequent codes of the said sequence of graphic codes. - said security being formed by a sequence of alphanumeric characters and/or symbols, - said dynamic graphic code consisting in a timely sequence of graphic codes to be provided on a display, - each graphic code of the sequence being a bar code or QR code containing information, - said information contained in each graphic code of the said sequence comprises a fixed part and a variable part, - each variable part being time dependent, - each variable part is encoded together with the respective fixed part thereby forming said sequence of different graphic codes, - each fixed part contains said security, - each fixed part can be determined by comparing two or more subsequent codes of the said sequence of graphic codes.
Occipital-cervical fixation equipment comprising: - an occipital plate able to be fixed to an occipital portion of the skull of a patient; - two longitudinal lateral bars able to be arranged in a sagittal direction alongside the spinous processes of the vertebrae of the patient, each longitudinal lateral bar extending between an occipital end portion and a vertebral end portion; - first fixation means configured to fix said occipital end portion of each longitudinal lateral bar and said occipital plate; - second fixation means configured to fix said longitudinal lateral bars to a patient's vertebra; - a transverse connector comprising: - a central longitudinal bar able to be arranged according to the sagittal direction between the two longitudinal lateral bars, said central longitudinal bar extending between an occipital end portion and a vertebral end portion, and - a cross bar associated with said central longitudinal bar and extending transversely thereto between two lateral end portions, - third fixation means configured to fix said occipital end portion of said longitudinal central bar to said occipital plate; - fourth fixation means configured to fix said lateral end portions of the cross bar respectively to one of two longitudinal lateral bars. - an occipital plate able to be fixed to an occipital portion of the skull of a patient; - two longitudinal lateral bars able to be arranged in a sagittal direction alongside the spinous processes of the vertebrae of the patient, each longitudinal lateral bar extending between an occipital end portion and a vertebral end portion; - first fixation means configured to fix said occipital end portion of each longitudinal lateral bar and said occipital plate; - second fixation means configured to fix said longitudinal lateral bars to a patient's vertebra; - a transverse connector comprising: - a central longitudinal bar able to be arranged according to the sagittal direction between the two longitudinal lateral bars, said central longitudinal bar extending between an occipital end portion and a vertebral end portion, and - a cross bar associated with said central longitudinal bar and extending transversely thereto between two lateral end portions, - a central longitudinal bar able to be arranged according to the sagittal direction between the two longitudinal lateral bars, said central longitudinal bar extending between an occipital end portion and a vertebral end portion, and - a cross bar associated with said central longitudinal bar and extending transversely thereto between two lateral end portions, - third fixation means configured to fix said occipital end portion of said longitudinal central bar to said occipital plate; - fourth fixation means configured to fix said lateral end portions of the cross bar respectively to one of two longitudinal lateral bars.
Filter element for fluid filters, having an element body comprising a longitudinal axis, containing a filter means through which fluid is able to flow, and having at least one connecting socket (21; 121; 221) which is open on the front face at one end of the element body for the releasable fastening of the filter element to a through-opening in a retaining device in the fluid filter, wherein the connecting socket (21; 121; 221) comprises a lateral surface (22; 122; 222) having a polygonal cross section with flat portions (26; 126; 226) and curved transitions (27; 127; 227) alternating with one another and a bearing surface for a sealing ring, which bearing surface is having a polygonal cross section with flat portions (36; 136; 236) and curved transitions (37; 137; 237) alternating with one another, characterized in that a receiving groove (33; 133; 233) is provided for the sealing ring on the outer periphery of the lateral surface of the connecting socket (21; 121; 221), the groove base (33A; 133A; 233A) of said receiving groove provides an inner radial bearing surface for the sealing ring and is having the polygonal cross section with the flat portions (36; 136; 236) and the curved transitions (37; 137; 237) alternating with one another, wherein the sealing ring in the groove base serves for cooperating with an internal wall of the through-opening in the retaining device and is an O-Ring.
A formulation comprising a peptide, wherein the peptide comprises an amino acid sequence with the formula LRRFSTXPXXXXDINDVXNF (SEQ ID NO: 4) or LRRFSTXPXXXXNINNVXNF (SEQ ID NO: 2), where X is a standard amino acid or non-genetically encoded amino acid, wherein the formulation comprises from 100 μg to about 1000 μg of the peptide agent, wherein the formulation does not involve encapsulation into particles, for use in the treatment of diabetic macular edema, retinal vein occlusion, wet age-related macular degeneration (wet AMD), or diabetic retinopathy, by intravitreal injection wherein the frequency of administration is no more frequent than about once every three months. wherein the formulation comprises from 100 μg to about 1000 μg of the peptide agent, wherein the formulation does not involve encapsulation into particles, for use in the treatment of diabetic macular edema, retinal vein occlusion, wet age-related macular degeneration (wet AMD), or diabetic retinopathy, by intravitreal injection wherein the frequency of administration is no more frequent than about once every three months.
A method for controlling a first user equipment, UE, to access a communications network of a high-speed moving vehicle, comprising: determining, by a core network control plane node device, that the first UE accessing the communications network of the high-speed moving vehicle is a first-type UE, wherein the first-type UE is a UE used by a user taking the high-speed moving vehicle; allocating, by the core network control plane node device, a first temporary identifier to the first UE, wherein the first temporary identifier comprises a first sequence, and the first sequence is used to indicate that the first UE is a first-type UE; and sending, by the core network control plane node device, the first temporary identifier to the first UE, wherein when the first UE accesses a public network, the first sequence is used to instruct a base station to transfer the first UE to the communications network of the high-speed moving vehicle; wherein the first UE generates a radio resource control, RRC, setup request message that carries the first sequence to access a public network, sends the RRC setup request message to the base station of the public network, the base station generates an RRC connection release message according to the first sequence, sends the RRC connection release message to the first UE, and instructs the first UE to access the communications network of the high-speed moving vehicle. determining, by a core network control plane node device, that the first UE accessing the communications network of the high-speed moving vehicle is a first-type UE, wherein the first-type UE is a UE used by a user taking the high-speed moving vehicle; allocating, by the core network control plane node device, a first temporary identifier to the first UE, wherein the first temporary identifier comprises a first sequence, and the first sequence is used to indicate that the first UE is a first-type UE; and sending, by the core network control plane node device, the first temporary identifier to the first UE, wherein when the first UE accesses a public network, the first sequence is used to instruct a base station to transfer the first UE to the communications network of the high-speed moving vehicle; wherein the first UE generates a radio resource control, RRC, setup request message that carries the first sequence to access a public network, sends the RRC setup request message to the base station of the public network, the base station generates an RRC connection release message according to the first sequence, sends the RRC connection release message to the first UE, and instructs the first UE to access the communications network of the high-speed moving vehicle.